Lemaitre Vascular (LMAT) Tops Q2 EPS by 4c, Beats on Revenue; Offers FY23 Guidance

Lemaitre Vascular (NASDAQ: LMAT) reported Q2 EPS of $0.36, $0.04 better than the analyst estimate of $0.32. Revenue for the quarter came in at $50.1 million versus the consensus estimate of $48.08 million.

GUIDANCE:

Lemaitre Vascular sees FY2023 EPS of $1.25-$1.35, versus the consensus of $1.20. Lemaitre Vascular sees FY2023 revenue of $193-198 million, versus the consensus of $189.9 million.

For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.

You May Also Be Interested In

• H&R Block (HRB) Tops Q4 EPS by 7c, Offers Guidance
• National CineMedia (NCMI) Misses Q2 EPS by 7c
• NeuroPace (NPCE) Tops Q2 EPS by 3c